AbbVie, Inc. (ABBV)

87.13
0.46 0.53
NYSE
Prev Close 87.59
Open 88.17
Day Low/High 86.73 / 88.17
52 Wk Low/High 62.55 / 101.28
Volume 5.16M
Exchange NYSE
Shares Outstanding 1764.83B
Market Cap 153.35B
P/E Ratio 74.91
Div & Yield N.A. (N.A)

From the Street of Dreams

Deutsche Bank reiterates its Buy recommendation on Gilead (GILD) (price target $125) based on the company's exclusive agreement with AbbVie (ABBV) for its HCV drug.

The Biotechs Are Back

Watch this leadership group that's been lagging.

There Are Still a Few Bargains Around

There Are Still a Few Bargains Around

They're in the tech, pharma and biotechnology sectors.

Abbvie rated new Sell at Citi

Abbvie estimates, target reduced at BMO

Getting Defensive Now

Getting Defensive Now

I am adding allocation to healthcare.

JP Morgan Healthcare Conf.

Abbvie downgraded at BofA/Merrill

Why I'm Sticking With Biotech

Why I'm Sticking With Biotech

They offer a nice shelter for the headwinds now hitting equities.

Gilead Is Set to Surge

Its hepatitis C drug will dominate the market.

Gilead Is a Buying Opportunity

Gilead Is a Buying Opportunity

Its hepatitis C drug is better; the stock trades at a discount.

Heed the Rotation

Stocks that do well when the economy rises are shining.

In Defense of Gilead Sciences

In Defense of Gilead Sciences

It has a great long-term future.

How Competition Hurts a Stock

It might be good for consumers, but not for the stock.

Three Large-Cap Growth Stocks

Three Large-Cap Growth Stocks

I would pick up some large caps on any significant dips.

Abbvie downgraded at Morgan Stanley

Buy Gilead Sciences

Buy Gilead Sciences

Its prospects exploded with a breakthrough drug.

AbbVie downgraded at BMO

Avoid the Crowd

There is virtually no room for error in a crowded trade.

Boxes: Checked!

Boxes: Checked!

We now have an investable bottom on our hands.

Run for Shelter in Community Banks

It's unlikely that they will be hit by Europe or the Ebola scare. 

We Aren't Done Yet

There will likely be more selling until the elusive bottom is reached.

This Morning's Market Setup

 Where it began. The rundown: U.S. futures are bouncing all over (now at their lows). S&P 500 futures are -16 and Nasdaq futures are -31 handles. Europe is broadly lower .  Japan is +0.92% following a quiet night of news. The yen has weakened a bit ...

Five Things to Know Now: Apple, Facebook and Women

The two tech giants help women freeze their eggs.

U.S. Stories Offset European Weakness

We are buying the weakness, albeit slowly.

AbbVie upgraded at UBS

European Markets Are Spooked by Ukraine and Gaza, but AbbVie Gets Shire Deal

European Markets Are Spooked by Ukraine and Gaza, but AbbVie Gets Shire Deal

European markets followed New York and Asia down this morning as investors were spooked by the shooting down of a Malaysian Airlines plane over Eastern Ukraine.